fas inhibitor c75 (Cayman Chemical)
Structured Review

Fas Inhibitor C75, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fas+inhibitor+c75/c75+fasn+inhibitor/pmc09292025-33-0-13
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Increased lipogenesis is critical for self‐renewal and growth of breast cancer stem cells: Impact of omega‐3 fatty acids"
Article Title: Increased lipogenesis is critical for self‐renewal and growth of breast cancer stem cells: Impact of omega‐3 fatty acids
Journal: Stem Cells
doi: 10.1002/stem.3452
Figure Legend Snippet: Characteristics of lipid metabolism in breast cancer stem cells. A,B, Representative images of mammosphere cells (MCF‐7‐CSC) derived from MCF‐7 cell line (A) and EMT‐CSC induced from HMLE‐Twist‐ER cells (B). C,D, Comparison of the profiles of SFA and MUFA (top and middle), and of C18:2n‐6 and C20:4n‐6 PUFA (bottom) in MCF‐7‐CSC (C) and EMT‐CSC (D) compared with their parental cells, respectively. E,F, Representative Western blot for protein expressions of FAS, SCD1, and FADS2 in MCF‐7‐CSC (E) and EMT‐CSC (F) compared with their parental cells, respectively. G,H, Relative densiometric bar graphs of FAS, SCD1, and FADS2 in MCF‐7‐CSC (G) and EMT‐CSC (H) compared with their parental cells, respectively. * P < .05; ** P < .01 vs parental cells. All the experiments were repeated at least three times. CSC, cancer stem cells; EMT, epithelial‐mesenchymal transition; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids
Techniques Used: Derivative Assay, Comparison, Western Blot
Figure Legend Snippet: Increased expression of the lipogenic enzymes in human breast cancer tissues. A,C,E, Representative image of IHC analysis for SCD1 (A), FAS (C), and FADS1 (E) expressions in normal and tumor tissues. ANT, tumor‐adjacent normal tissue; T, tumor. B,D,F, Representative image of immunohistochemistry (IHC) analysis for SCD1 (B), FAS (D), and FADS1 (F) expressions between various clinical and tumor grades (G1‐3). *** P < .001 vs vehicle‐treated control cells. Alphabet letters were used to show the significant difference between groups. Each subfigure contains representative image (top) and quantitative results (bottom). The quantitative results were plotted by the values of minimum to maximum
Techniques Used: Expressing, Immunohistochemistry, Control
Figure Legend Snippet: n‐3 PUFA inhibit tumor growth of breast cancer stem cells in xenograft mouse model. A, Representative image of tumor‐bearing mice. Prior to implanting 1.5 × 10 7 of MCF‐7‐CSC to nude mice, these mice were orally gavaged by either fish oil (n‐3 PUFA) or corn oil (control) for a month and continued giving oils until the end of the experiment. B, Tumor growth of the nude mice in each group. C, Relative tumor weight by body weight. D, The ratio of n‐6/n‐3 PUFA. E, The ratio of MUFA (C16:1 + C18:1)/SFA (C16:0 + C18:0). F, The ratio of C20:4/C18:2. G,H, Protein levels (G) and mRNA levels (H) of SCD1, FAS, FADS2, and COX2 between control and n‐3 PUFA groups. n = 3 to 4. * P < .05; ** P < .01; *** P < .001 vs control. MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids; SFA, saturated fatty acids
Techniques Used: Control
Related Articles
Control:Article Title: Metabolic control of the scaffold protein TKS5 in tissue-invasive, pro-inflammatory T cells Article Snippet: .. For experiments targeting anabolic lipogenesis, chimeric mice carrying the same synovial tissue were randomly assigned to three treatment arms: (A) control (vehicle); (B) treatment with |
